Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

S. Lonardi; A. Sobrero; G. Rosati; M. Di Bartolomeo; M. Ronzoni; G. Aprile; Mario Scartozzi; M. Banzi; M.G. Zampino; F. Pasini; P. Marchetti; M. Cantore; A. Zaniboni; L. Rimassa; L. Ciuffreda; D. Ferrari; S. Barni; V. Zagonel; E. Maiello; E. Rulli; R. Labianca

doi:10.1093/annonc/mdw404

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

S. Lonardi, A. Sobrero, G. Rosati, M. Di Bartolomeo, M. Ronzoni, G. Aprile, Mario Scartozzi, M. Banzi, M.G. Zampino, F. Pasini, P. Marchetti, M. Cantore, A. Zaniboni, L. Rimassa, L. Ciuffreda, D. Ferrari, S. Barni, V. Zagonel, E. Maiello, E. RulliR. Labianca

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2074-2081
Number of pages	8
Journal	Annals of Oncology
Volume	27
Issue number	11
DOIs	https://doi.org/10.1093/annonc/mdw404
Publication status	Published - 2016

Access to Document

10.1093/annonc/mdw404

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84997417107&doi=10.1093%2fannonc%2fmdw404&partnerID=40&md5=c0bb354be8d73701d5ca5efcb015a996

Cite this

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., ... Labianca, R. (2016). Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial. Annals of Oncology, 27(11), 2074-2081. https://doi.org/10.1093/annonc/mdw404

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial. / Lonardi, S.; Sobrero, A.; Rosati, G.; Di Bartolomeo, M.; Ronzoni, M.; Aprile, G.; Scartozzi, Mario; Banzi, M.; Zampino, M.G.; Pasini, F.; Marchetti, P.; Cantore, M.; Zaniboni, A.; Rimassa, L.; Ciuffreda, L.; Ferrari, D.; Barni, S.; Zagonel, V.; Maiello, E.; Rulli, E.; Labianca, R.

In: Annals of Oncology, Vol. 27, No. 11, 2016, p. 2074-2081.

Research output: Contribution to journal › Article › peer-review

Lonardi, S , Sobrero, A, Rosati, G, Di Bartolomeo, M , Ronzoni, M, Aprile, G, Scartozzi, M, Banzi, M , Zampino, MG, Pasini, F, Marchetti, P, Cantore, M, Zaniboni, A , Rimassa, L, Ciuffreda, L, Ferrari, D, Barni, S, Zagonel, V , Maiello, E , Rulli, E & Labianca, R 2016, 'Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial', Annals of Oncology, vol. 27, no. 11, pp. 2074-2081. https://doi.org/10.1093/annonc/mdw404

Lonardi, S. ; Sobrero, A. ; Rosati, G. ; Di Bartolomeo, M. ; Ronzoni, M. ; Aprile, G. ; Scartozzi, Mario ; Banzi, M. ; Zampino, M.G. ; Pasini, F. ; Marchetti, P. ; Cantore, M. ; Zaniboni, A. ; Rimassa, L. ; Ciuffreda, L. ; Ferrari, D. ; Barni, S. ; Zagonel, V. ; Maiello, E. ; Rulli, E. ; Labianca, R. / Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial. In: Annals of Oncology. 2016 ; Vol. 27, No. 11. pp. 2074-2081.

@article{f05d8971e9d94b99bb0714a01e1d52ea,

title = "Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial",

author = "S. Lonardi and A. Sobrero and G. Rosati and {Di Bartolomeo}, M. and M. Ronzoni and G. Aprile and Mario Scartozzi and M. Banzi and M.G. Zampino and F. Pasini and P. Marchetti and M. Cantore and A. Zaniboni and L. Rimassa and L. Ciuffreda and D. Ferrari and S. Barni and V. Zagonel and E. Maiello and E. Rulli and R. Labianca",

note = "Export Date: 20 March 2017",

year = "2016",

doi = "10.1093/annonc/mdw404",

language = "English",

volume = "27",

pages = "2074--2081",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "11",

}

TY - JOUR

T1 - Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

AU - Lonardi, S.

AU - Sobrero, A.

AU - Rosati, G.

AU - Di Bartolomeo, M.

AU - Ronzoni, M.

AU - Aprile, G.

AU - Scartozzi, Mario

AU - Banzi, M.

AU - Zampino, M.G.

AU - Pasini, F.

AU - Marchetti, P.

AU - Cantore, M.

AU - Zaniboni, A.

AU - Rimassa, L.

AU - Ciuffreda, L.

AU - Ferrari, D.

AU - Barni, S.

AU - Zagonel, V.

AU - Maiello, E.

AU - Rulli, E.

AU - Labianca, R.

N1 - Export Date: 20 March 2017

PY - 2016

Y1 - 2016

U2 - 10.1093/annonc/mdw404

DO - 10.1093/annonc/mdw404

M3 - Article

VL - 27

SP - 2074

EP - 2081

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 11

ER -